You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

prediction adverse event

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Suspicion of Cardiovascular Events on Immunecheckpoint

Recruiting
  • Cancer
  • +3 more
  • No intervention for research purposes only
  • Paris, France
    Intitut Mutualiste Montsouris
Mar 23, 2023

irAE Prediction of Anti-PD-1/L1 in Lung Cancer

Recruiting
  • Immune Checkpoint Inhibitors
  • Lung Cancer
    • Beijing, China
      Peking Union Medical College Hospital
    Mar 31, 2022

    Emergencies Trial in Montréal (ER2)

    Not yet recruiting
    • Emergencies
    • ER2
    • Montréal, Quebec, Canada
      Jewish General Hospital
    Aug 11, 2022

    From External Registries on Nonacog Beta Pegol

    Enrolling by invitation
    • Haemophilia B
    • Nonacog beta pegol
    • Baarn, Netherlands
    • +1 more
    Jan 7, 2022

    Improving Care Pathway Using Simplified Digital Tools for

    Not yet recruiting
    • Oncology
    • +5 more
    • Nouveal numeric application "Onco'nect"
    • (no location specified)
    Jul 21, 2023

    Adverse Drug Events Associated With Initiation of Drugs

    Completed
    • COVID
    • +3 more
    • Simulation of Repurposed Drugs for COVID-19
    • Orlando, Florida
      Tabula Rasa HealthCare Precision Pharmacotherapy Research and De
    Jan 30, 2023

    Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

    Recruiting
    • Tumor Infiltrating Lymphocytes
    • +4 more
    • GC101 TIL
    • Beijing, China
      Beijing Cancer Hospital
    Nov 7, 2023

    Medication Adherence, Medication Nonadherence, Adverse Drug Event Trial in Lexington (Collaborative nurse-pharmacist counseling)

    Not yet recruiting
    • Medication Adherence
    • +2 more
    • Collaborative nurse-pharmacist counseling
    • Lexington, Kentucky
      University of Kentucky
    Apr 3, 2023

    Cancer Trial in Changsha (Protein Kinase Inhibitor)

    Recruiting
    • Cancer
    • Protein Kinase Inhibitor
    • Changsha, Hunan, China
      Central South University
    Jun 23, 2022

    NSCLC Trial (Anlotinib)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Jan 19, 2022

    Adverse Events Associated With Manual Therapies in Children

    Completed
    • Adverse Event
    • Manual therapies
    • Trois-Rivières, Quebec, Canada
      Université du Québec à Trois-Rivières
    Jun 9, 2022

    Aging, Benzodiazepine Sedative Adverse Reaction, Anticholinergic Adverse Reaction Trial in Boston (Follow-up booster Alert,

    Not yet recruiting
    • Aging
    • +3 more
    • Follow-up booster Alert
    • +2 more
    • Boston, Massachusetts
      Mass General Brigham
    Sep 9, 2022

    Adverse Drug Event Trial in Madrid (Pharmacovigilance Program)

    Recruiting
    • Adverse Drug Event
    • Pharmacovigilance Program
    • Madrid, Spain
      Hospital San Carlos
    Aug 2, 2022

    Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

    Not yet recruiting
    • Inflammatory Arthritis
    • Immune-related Adverse Event
    • (no location specified)
    Sep 13, 2023

    Pain, Quality of Life, Injection Site Reaction Trial in Durham (FLUAD® Quadrivalent, Fluzone® HD Quadrivalent, SHINGRIX®)

    Recruiting
    • Pain
    • +3 more
    • FLUAD® Quadrivalent
    • +2 more
    • Durham, North Carolina
      Duke University
    Jan 19, 2023

    Multiple Chronic Conditions, Adverse Event Trial in Boston (ePRO Application)

    Recruiting
    • Multiple Chronic Conditions
    • Adverse Event
    • ePRO Application
    • Boston, Massachusetts
    • +1 more
    Mar 7, 2022

    Cancer Trial in Kufstein (Patient-reported outcomes assessment, CTCAE rating, PRO data is displayed)

    Recruiting
    • Cancer
    • Patient-reported outcomes assessment
    • +2 more
    • Kufstein, Austria
      Bezirkskrankenhaus Kufstein
    Apr 5, 2022

    Rechallenge of BRAF +/- MEK Inhibitors FollowingAdverse Event in

    Active, not recruiting
    • Cancer
    • BRAF inhibitor
    • (no location specified)
    Oct 13, 2021

    Septic Shock, Adverse Event, Hydrocortisone Trial in Bangkok (normal saline solution, Hydrocortisone and normal saline solution)

    Not yet recruiting
    • Septic Shock
    • +6 more
    • normal saline solution
    • Hydrocortisone and normal saline solution
    • Bangkok, Thailand
      Department of Medicine, Faculty of Medicine Siriraj Hospital, Ma
    Apr 18, 2023

    Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

    Recruiting
    • Oncolytic Virus
    • +2 more
    • Ad-TD-nsIL12
    • Beijing, Beijing, China
      Sanbo Brain Hospital, Capital Medical University
    Jan 29, 2023

    Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

    Recruiting
    • Oncolytic Virus
    • +2 more
    • Ad-TD-nsIL12
    • Beijing, Beijing, China
      Sanbo Brain Hospital, Capital Medical University
    Jan 29, 2023

    Baseline Concentration of Direct Oral Anticoagulant and

    Recruiting
    • Atrial Fibrillation
    • Anticoagulant-induced Bleeding
      • Cremona, Italy
        Sophie Testa
      Jul 19, 2022

      Gender Bias in the Overuse Studies Conducting in Primary Care

      Active, not recruiting
      • Severe Adverse Event
      • "Do not do" recommendation
      • Elche, Alicante, Spain
        Miguel Hernández University
      Nov 2, 2022

      Adverse Events in Patients Treated With Immune Check Point

      Recruiting
      • Immune-related Adverse Event
      • Antiinflammatory/DMARDs
      • Kristiansand, Norway
      • +4 more
      Sep 15, 2022

      Phage Safety Cohort Study

      Recruiting
      • Prosthetic Joint Infection
      • Severe Infection
      • Adverse event after injection of phages
      • Lyon, France
        Hospices Civils de Lyon
      May 20, 2022